Table 3. Published studies on primary chemotherapy in patients with NSGCT.

Author (year)	Number of patients with non-seminoma	Residual disease	Teratoma	Necrosis/scar
Calvo et al (1983) [5]	5	3	0	2
Chong et al (1986) [8]	11	3	3	5
Leibovitch et al (1996) [11]	160	40	50	70
Geldart et al (2002) [13]	42	3	18	21
Ramani et al (2008) [16]	20	6	6	8
Miller et al (2012) [17]a	36	8	15	13
Total	274	63 (22.9%)	92 (33.5%)	119 (43.4%)

^aBy personal contact.